Skip to Main Content

The Indian government has banned exports of hydroxychloroquine, the decades-old malaria drug that was touted by President Trump as a possible weapon in the fight against Covid-19, but has been in short supply.

In a notice posted Wednesday, the Directorate General of Foreign Trade prohibited the medicine and any formulations from being shipped outside of the country, except for companies that must fulfill existing contracts and on humanitarian grounds that would have to be approved on a case-by-case basis by the Ministry of External Affairs.


The move comes amid heightened speculation over the extent to which the drug can be effective in combating the novel coronavirus, since clinical trials have not been conducted for use in Covid-19 patients. The drug, which is also approved to treat lupus and rheumatoid arthritis, is among four medicines that will be the focus of a large study announced last week by the World Health Organization.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.